Revealed: Strategic Dynamics Steering the Biosimilar Contract Manufacturing Market Share
The evolving landscape of the biosimilar contract manufacturing market reveals profound dynamics that are influencing market share across various segments. With a projected market size of USD 51.9 billion by 2035, the sector is experiencing a robust compound annual growth rate (CAGR) of 18.9%. This growth is driven by escalating healthcare costs and a pressing need for cost-effective biologics....
0 Comments 0 Shares 111 Views 0 Reviews